You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 13, April 2, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Drug Therapy, Other
 •Neurology
 •Cognitive Disorders
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Psychiatry
 •Delirium
 •Alert me on articles by topic

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Pandharipande and colleagues1 studied the effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients and found that the use of dexmedetomidine infusion resulted in more days alive without delirium or coma and more time at the targeted level of sedation. However, because of the lorazepam dosing strategy we believe that the results of this trial have limited generalizability.

Clinical practice guidelines give preference to intravenous push (or bolus dosing) of lorazepam and recommend that continuous lorazepam infusions only be used in patients who require frequent intravenous push doses.2 Acutely agitated patients should be given bolus doses initially in addition to increasing the rate of the infusion.2 However, in this study all patients received lorazepam as a continuous infusion, and agitated patients were not able to receive lorazepam boluses. The use of a continuous infusion has been associated with an increase . . . [Full Text of this Article]

Bryan Dotson, PharmD
bryan.dotson@utoledo.edu

Michael J. Peeters, PharmD
University of Toledo Medical Center
Toledo, Ohio


RELATED ARTICLE

Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated Patients: The MENDS Randomized Controlled Trial
Pratik P. Pandharipande, Brenda T. Pun, Daniel L. Herr, Mervyn Maze, Timothy D. Girard, Russell R. Miller, Ayumi K. Shintani, Jennifer L. Thompson, James C. Jackson, Stephen A. Deppen, Renee A. Stiles, Robert S. Dittus, Gordon R. Bernard, and E. Wesley Ely
JAMA. 2007;298(22):2644-2653.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Hannah Wunsch and Joseph S. Meltzer
JAMA. 2008;299(13):1540-1541.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients
Jeffrey F. Barletta and John W. Devlin
JAMA. 2008;299(13):1541-1542.
EXTRACT | FULL TEXT  

Sedation With Dexmedetomidine vs Lorazepam in Mechanically Ventilated Patients—Reply
Pratik P. Pandharipande, Timothy D. Girard, and E. Wesley Ely
JAMA. 2008;299(13):1542.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.